Loading clinical trials...
Loading clinical trials...
Professional Impact of Osteoarticular Trauma: Retrospective Study on Return to Work, Accommodations, and Recognition in the Workplace
This study aims to describe the medical, social, and organizational determinants of returning to work after an osteoarticular injury, particularly limb fractures. Using observational data, the study will evaluate the modalities of returning to work within 12 months of the injury and analyze the factors influencing professional reintegration, including the severity of the injury, functional recovery, pain, professional characteristics, workplace accommodations, and administrative support measures such as recognition of disabled worker status. The study will also explore the point at which the issue of returning to work is first raised with the patient during hospitalization, a period during which professional reintegration is often insufficiently anticipated. By identifying current practices and breaking points, this study aims to improve understanding of the pathways to returning to work in the context of the healthcare system and the world of work in France.
Osteoarticular trauma, particularly limb fractures, is a major public health problem and frequently affects young people of working age. These injuries often result in prolonged interruption of professional activity and significant socioeconomic consequences. Returning to work is a key step in the rehabilitation process after trauma, but it is influenced by a wide range of medical, social, and organizational factors. Medical determinants include the severity of the injuries, functional limitations, pain, and long-term sequelae. In addition, professional and social factors such as the type of job, employer support, the possibility of workplace accommodations, and administrative procedures related to disability recognition can strongly influence the terms of return to work. Beyond clinical recovery, the organization of care pathways and coordination with occupational health services also play a decisive role in professional reintegration. This observational study aims to describe the pathways to return to work after osteoarticular trauma in the French context. It will assess the rate of return to work within 12 months of the trauma, as well as the time taken to resume professional activity. It will also analyze the medical, social, and professional factors associated with returning to work, including workplace accommodations and the implementation of administrative measures related to disability. The study will further explore the point at which the issue of return to work is first raised with patients during hospitalization. This period is a critical phase during which professional reintegration is often insufficiently anticipated. By identifying current practices and the timing of these discussions, the study aims to better characterize existing gaps in the early anticipation of professional return. By providing descriptive data on the determinants of return to work after osteoarticular trauma, this study aims to improve understanding of professional reintegration pathways and guide the development of future strategies that promote earlier anticipation and enhanced coordination of return to work within healthcare systems and the world of work.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Hôpitaux Paris Est Val-de-Marne - Service de rééducation orthopédique et traumatologie
Saint-Maurice, France
Start Date
February 18, 2026
Primary Completion Date
July 2, 2026
Completion Date
February 2, 2027
Last Updated
February 23, 2026
200
ESTIMATED participants
Lead Sponsor
Hopitaux de Saint-Maurice
NCT07485530
NCT07450274
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06505109